Design Therapeutics Statistics

Total Valuation

DSGN has a market cap or net worth of $180.78 million. The enterprise value is -$87.76 million.

Market Cap	180.78M
Enterprise Value	-87.76M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

DSGN has 56.50 million shares outstanding. The number of shares has increased by 1.04% in one year.

Shares Outstanding	56.50M
Shares Change (YoY)	+1.04%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	36.54%
Owned by Institutions (%)	54.64%
Float	24.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.67
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.61, with a Debt / Equity ratio of 0.01.

Current Ratio	38.61
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -20.80% and return on invested capital (ROIC) is -26.11%.

Return on Equity (ROE)	-20.80%
Return on Assets (ROA)	-19.90%
Return on Capital (ROIC)	-26.11%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.46% in the last 52 weeks. The beta is 1.88, so DSGN's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	-50.46%
50-Day Moving Average	3.91
200-Day Moving Average	2.93
Relative Strength Index (RSI)	34.73
Average Volume (20 Days)	174,302

Short Selling Information

The latest short interest is 2.87 million, so 5.08% of the outstanding shares have been sold short.

Short Interest	2.87M
Short Previous Month	2.80M
Short % of Shares Out	5.08%
Short % of Float	11.80%
Short Ratio (days to cover)	20.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-70.94M
Pretax Income	-58.67M
Net Income	-58.67M
EBITDA	-58.10M
EBIT	-58.67M
Earnings Per Share (EPS)	-$1.05

Full Income Statement

Balance Sheet

The company has $270.69 million in cash and $2.14 million in debt, giving a net cash position of $268.54 million or $4.75 per share.

Cash & Cash Equivalents	270.69M
Total Debt	2.14M
Net Cash	268.54M
Net Cash Per Share	$4.75
Equity (Book Value)	269.56M
Book Value Per Share	4.77
Working Capital	266.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.58 million and capital expenditures -$364,000, giving a free cash flow of -$53.94 million.

Operating Cash Flow	-53.58M
Capital Expenditures	-364,000
Free Cash Flow	-53.94M
FCF Per Share	-$0.96

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.04%
Shareholder Yield	-1.04%
Earnings Yield	-32.45%
FCF Yield	-29.84%

Analyst Forecast

The average price target for DSGN is $6.75, which is 110.94% higher than the current price. The consensus rating is "Hold".

Price Target	$6.75
Price Target Difference	110.94%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	4.01%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3